Genetic analysis of myeloid neoplasms with der(1;7)(q10;p10).

Autor: Okuda R; Department of Pathology and Tumor Biology, Graduate School of Medicine, Kyoto University, Kyoto, Japan., Ochi Y; Department of Pathology and Tumor Biology, Graduate School of Medicine, Kyoto University, Kyoto, Japan. ochi.yotaro.24v@kyoto-u.jp., Saiki R; Department of Pathology and Tumor Biology, Graduate School of Medicine, Kyoto University, Kyoto, Japan., Yamanaka T; Department of Pathology and Tumor Biology, Graduate School of Medicine, Kyoto University, Kyoto, Japan., Terao C; Laboratory for Statistical and Translational Genetics, RIKEN Center for Integrative Medical Sciences, Yokohama, Japan.; Clinical Research Center, Shizuoka General Hospital, Shizuoka, Japan.; The Department of Applied Genetics, The School of Pharmaceutical Sciences, University of Shizuoka, Shizuoka, Japan., Yoshizato T; Department of Pathology and Tumor Biology, Graduate School of Medicine, Kyoto University, Kyoto, Japan., Nakagawa MM; Department of Pathology and Tumor Biology, Graduate School of Medicine, Kyoto University, Kyoto, Japan., Zhao L; Department of Pathology and Tumor Biology, Graduate School of Medicine, Kyoto University, Kyoto, Japan., Ohyashiki K; Department of Hematology, Tokyo Medical University, Tokyo, Japan., Hiramoto N; Department of Hematology, Kobe City Medical Center General Hospital, Hyogo, Japan., Sanada M; Department of Pathology and Tumor Biology, Graduate School of Medicine, Kyoto University, Kyoto, Japan.; Department of Advanced Diagnosis, Clinical Research Center, NHO Nagoya Medical Center, Nagoya, Japan., Handa H; Department of Hematology, Graduate School of Medicine, Gunma University, Gunma, Japan., Kasahara S; Department of Hematology, Gifu Municipal Hospital, Gifu, Japan., Miyazaki Y; Japan Adult Leukemia Study Group, and Department of Hematology, Atomic Bomb Disease Institute, Nagasaki University, Nagasaki, Japan., Sezaki N; Department of Hematology, Chugoku Central Hospital, Hiroshima, Japan., Shih LY; Division of Hematology-Oncology, Chang Gung Memorial Hospital-Linkou, Chang Gung University, Taoyuan, Taiwan., Kern W; MLL Munich Leukemia Laboratory, Munich, Germany., Kanemura N; Department of Hematology and Infectious Disease, Gifu University Graduate School of Medicine, Gifu, Japan., Kitano T; Department of Hematology, Tazuke Kofukai, Medical Research Institute, Kitano Hospital, Osaka, Japan., Imashuku S; Department of Laboratory Medicine, Uji-Tokushukai Medical Center, Uji, Japan., Watanabe M; Department of Hematology, Hyogo Prefectural Amagasaki General Medical Center, Hyogo, Japan., Creignou M; Department of Medicine Huddinge, Center for Hematology and Regenerative Medicine, Karolinska Institutet, Stockholm, Sweden.; Center for Clinical Cancer Studies, Phase 1 Unit, Karolinska University Hospital, Stockholm, Sweden., Chonabayashi K; Department of Cell Growth and Differentiation, Center for iPS Research and Application, Kyoto University, Kyoto, Japan.; Department of Hematology, Graduate School of Medicine, Kyoto University, Kyoto, Japan., Usuki K; Department of Hematology, NTT Medical Center Tokyo, Tokyo, Japan., Ishikawa T; Department of Hematology, Kobe City Medical Center General Hospital, Hyogo, Japan., Gotoh A; Department of Hematology, Tokyo Medical University, Tokyo, Japan., Atsuta Y; The Japanese Data Center for Hematopoietic Cell Transplantation, Aichi, Japan.; Department of Registry Science for Transplant and Cellular Therapy, Aichi Medical University School of Medicine, Aichi, Japan., Shiraishi Y; Human Genome Center, Institute of Medical Science, The University of Tokyo, Tokyo, Japan., Mitani K; Department of Hematology and Oncology, Dokkyo Medical University, Tochigi, Japan., Chiba S; Department of Hematology, Institute of Medicine, University of Tsukuba, Ibaraki, Japan., Takaori-Kondo A; Department of Hematology, Graduate School of Medicine, Kyoto University, Kyoto, Japan., Miyano S; Human Genome Center, Institute of Medical Science, The University of Tokyo, Tokyo, Japan.; M&D Data Science Center, Tokyo Medical and Dental University, Tokyo, Japan., Kamatani Y; Department of Computational Biology and Medical Sciences, Graduate Schools of Frontier Sciences, The University of Tokyo, Tokyo, Japan., Haferlach T; MLL Munich Leukemia Laboratory, Munich, Germany., Hellström-Lindberg E; Department of Medicine Huddinge, Center for Hematology and Regenerative Medicine, Karolinska Institutet, Stockholm, Sweden.; Department of Hematology, Karolinska University Hospital, Stockholm, Sweden., Matsuda K; Department of Computational Biology and Medical Sciences, Graduate Schools of Frontier Sciences, The University of Tokyo, Tokyo, Japan., Yoshida Y; Department of Cell Growth and Differentiation, Center for iPS Research and Application, Kyoto University, Kyoto, Japan., Makishima H; Department of Pathology and Tumor Biology, Graduate School of Medicine, Kyoto University, Kyoto, Japan., Nannya Y; Department of Pathology and Tumor Biology, Graduate School of Medicine, Kyoto University, Kyoto, Japan., Ogawa S; Department of Pathology and Tumor Biology, Graduate School of Medicine, Kyoto University, Kyoto, Japan. sogawa-tky@umin.ac.jp.; Institute for the Advanced Study of Human Biology (WPI-ASHBi), Kyoto University, Kyoto, Japan. sogawa-tky@umin.ac.jp.

Publikováno v: Leukemia [Leukemia] 2024 Dec 23. Date of Electronic Publication: 2024 Dec 23.

Distinguishing xenotime and zircon in ores and estimating the xenotime content for on-site analysis.

Autor: Imashuku S; Institute for Materials Research, Tohoku University, 2-1-1 Katahira, Aoba-ku, Sendai 980-8577, Japan. Electronic address: susumu.imashuku@imr.tohoku.ac.jp.

Publikováno v: Spectrochimica acta. Part A, Molecular and biomolecular spectroscopy [Spectrochim Acta A Mol Biomol Spectrosc] 2024 Jul 05; Vol. 315, pp. 124216. Date of Electronic Publication: 2024 Mar 30.

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

P037 - Topic: AS04-MDS Biology and Pathogenesis/AS04a-Normal, MDS, and leukemic stem cells: DER(1;7)(Q10;P10) DEFINES A DISTINCT SUBTYPE OF MYELODYSPLASIA

Autor: Okuda, R., Ochi, Y., Saiki, R., Chonabayashi, K., Hiramoto, N., Sanada, M., Handa, H., Kasahara, S., Sato, S., Kanemura, N., Kitano, T., Watanabe, M., Kern, W., Creignou, M., Shiraishi, Y., Usuki, K., Imashuku, S., Hellstrom-Lindberg, E., Haferlach, T., Chiba, S., Sezaki, N., Shih, L.-Y., Miyazaki, Y., Yoshida, Y., Ishikawa, T., Ohyashiki, K., Atsuta, Y., Shiozawa, Y., Miyano, S., Makishima, H., Nannya, Y., Ogawa, S.

Publikováno v: In Leukemia Research May 2023 128 Supplement

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.